Effect of autologous adipose-derived mesenchymal stem cell therapy in the treatment of acromioclavicular joint osteoarthritis

BMJ Case Reports
Julien FreitagAbi Tenen

Abstract

The aim of this case report is to evaluate the efficacy of mesenchymal stem cell (MSC) therapy in the treatment of small joint osteoarthritis (OA). Acromio-clavicular (AC) joint OA is an under-diagnosed and yet frequent source of shoulder pain. MSCs have shown evidence of benefit in the treatment of knee OA. This is the first report to describe the use of MSC therapy in OA of the upper limb. A 43-year-old patient presents with painful AC joint OA and undergoes MSC therapy. The patient reported pain and functional improvement as assessed by the Disability of Arm, Shoulder and Hand Score and Numeric Pain Rating Scale. Imaging at 12 months showed structural improvement with reduction in subchondral oedema, synovitis and subchondral cysts. This case is the first to show the benefit of MSC therapy in the treatment of small joint arthropathy and also of the upper limb.Trial registration number: Australian New Zealand Clinical Trials Registry (ACTRN12617000638336).

References

Mar 1, 1988·The American Journal of Sports Medicine·F F Cook, J E Tibone
Jul 1, 1971·The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine·P Zanca
Jan 1, 1995·Journal of Shoulder and Elbow Surgery·E L FlatowL U Bigliani
Apr 1, 1996·AJR. American Journal of Roentgenology·S D NeedellJ W Uribe
May 27, 1999·The Journal of the American Academy of Orthopaedic Surgeons·B S Shaffer
May 17, 2002·The Journal of Hand Surgery·Nelson Fong SooHooGary R McGillivary
Dec 12, 2002·Molecular Biology of the Cell·Patricia A ZukMarc H Hedrick
Mar 11, 2004·The International Journal of Biochemistry & Cell Biology·Frank P Barry, J Mary Murphy
Nov 27, 2007·Journal of Tissue Engineering and Regenerative Medicine·Brian C GohJeffrey M Gimble
Apr 9, 2008·Stem Cells and Development·Linyi PengChunyan Zhou
Nov 22, 2008·The Journal of Pathology·A I Caplan
Mar 3, 2009·Tissue Engineering. Part C, Methods·Brunella GrigoloAndrea Facchini
May 4, 2010·Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association·Michael PensakBernard R Bach
Jan 26, 2012·Tissue Engineering. Part B, Reviews·Jingting Li, Ming Pei
Jun 18, 2014·Southern Medical Journal·Travis J MengeIan R Byram
Jul 14, 2016·Journal of Tissue Engineering and Regenerative Medicine·Oliver F W GardnerMartin J Stoddart
May 19, 2017·Tissue Engineering. Part B, Reviews·Marta A SzychlinskaGiuseppe Musumeci

❮ Previous
Next ❯

Citations

Sep 19, 2019·Reproductive Sciences·Andres ReigHugh S Taylor
May 20, 2020·Journal of Translational Medicine·Christopher J RogersBoris R Minev

❮ Previous
Next ❯

Software Mentioned

QuickDASH

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.